1540P Discovery of CD28-targeting single domain antibodies to facilitate the development of bi- or tri-specific T cell engager

Jian Xu(University of California, Los Angeles), Jie Gu(Jiangsu University), Lijie Wu(ShanghaiTech University), Xiao Ji(Southwestern Institute of Physics), Sipei Nie(Jiangsu Province Hospital), Yu‐Jui Yvonne Wan(University of California System), Hong Zhou(University of Calgary)
Annals of Oncology
September 1, 2025
10.1016/j.annonc.2025.08.2171
Cited by 0

Related Papers

HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
|Gastric Cancer|2014|615
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
|Molecular Carcinogenesis|2010|558
Drug resistance to targeted therapeutic strategies in non-small cell lung cancer
|Pharmacology & Therapeutics|2019|245
ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer
|Journal of Experimental & Clinical Cancer Research|2021|206
Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations
|Nature Genetics|2011|198